Cindy Leissinger, MD, is director of the Louisiana Center for Bleeding and Clotting Disorders and a professor at Tulane University School of Medicine.
New Hemophilia Treatment a Victory for Patients, Tulane Doctor Writes in New England Journal of Medicine
A new treatment that helps people with hemophilia A maintain higher levels of a crucial blood clotting factor with fewer treatments is a victory for patients, according to a new editorial in The New England Journal of Medicine this week by Cindy Leissinger, MD, director of the Louisiana Center for Bleeding and Clotting Disorders at Tulane University School of Medicine.
Read more about this victory for patients and the cutting-edge research that led to a new hemophilia treatment.
LCMC Health and Tulane University Announce Partnership
LCMC Health and Tulane University announced intentions to partner to expand access to comprehensive and specialty care across Southeast Louisiana, enhance the region’s capabilities as a destination for medical innovation and training, and provide community investments and benefits. Click here to read more.
Learn More About our Guiding Principles for our Community
Education, Patient Care, and Research: We Heal Communities
One of the nation's most recognized centers for medical education, Tulane University School of Medicine is a vibrant center for education, research and public service. Tulane University School of Medicine is the second-oldest medical school in the Deep South and the 15th oldest medical school in the United States. Tulane School of Medicine is fully accredited by the Liaison Committee on Medical Education.
Read more about Tulane School of Medicine Professionalism Program
You can give to the Tulane School of Medicine by using this secure link.
